Covid-19 vaccinesrare adverse eventsSARS-CoV-2vaccine efficacyvariants of concernSince the outbreak of coronavirus disease 2019 (Covid-19) in December 2019, caused by the severe acute respiratory syndrome coron
It is obvious that a successful COVID-19 vaccination program is needed to end the pandemic and allow a return to normal life5,6. By the end of February 2021, two COVID-19 vaccines had been approved in the U.S.: BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna)7. In two large ...
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both primary and booster vaccinations. However, given...
It was urgent and necessary to synthesize the evidence for vaccine effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a systematic review and meta-analysis to provide a comprehensive overview of the effectiveness profile of COVID-19 vaccines against VOC. Methods Publishe...
[04:17.52]After another year of face coverings, restrictions, [04:22.48]vaccines and variants, people are beginning [04:26.48]to wonder whether this pandemic will ever go away. [04:30.80]The answer is yes and no. ...
Get vaccinated.Vaccines are still the best public health step to protect people from serious illness from COVID-19. Wear a mask.Your mask will protect you and those around you from all variants. The CDC suggests that you wear a mask in pub...
AstraZeneca says the drug could benefit some 2% of the population who cannot mount an effective immune response from COVID-19 vaccines. "We hope to make AZD3152 available as a new prophylactic treatment in the second half of this year," said Pangalos. ...
A new virus was first reported in December 2019. The disease, COVID-19, spread quickly around the world. Here’s what you need to know about what the virus is, development of vaccines and treatments, variants like delta and omicron, and what technology c
Covid-19 and Parkinsonism 3 Covid-19 vaccinations 3.1 General information on the available Covid-19 vaccines As the prevalence of Covid-19 continues to surge globally, constituting a major global public health threat, and with limited therapeutic interventions available up to now, the development ...
Timely evaluation of the protective effects of Coronavirus Disease 2019 (COVID-19) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern is urgently needed to inform pandemic control planning. Based on 78 vaccine efficacy or effectiveness (VE) data from ...